How to use implantable loop recorders in clinical trials and hybrid therapy

Journal of Interventional Cardiac Electrophysiology

Volumn 32, Issue 3, 2011, Pages 227-232

  Jung, Werner ^a   Zvereva, Vlada ^a   Rillig, Andreas ^a   Roggenbuck, Birge ^a   Sadeghzadeh, Gholam ^a   Kohler, Johannes ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

AF monitoring; Atrial fibrillation; Cardiac monitoring; Implantable loop recorder

Indexed keywords

ALGORITHM; BRAIN ISCHEMIA; CARDIAC IMAGING; CARDIOVASCULAR EQUIPMENT; CATHETER ABLATION; CONFERENCE PAPER; ELECTROCARDIOGRAPHY MONITORING; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HEART VENTRICLE CONDUCTION; HOLTER MONITORING; HUMAN; IMPLANT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

ATRIAL FIBRILLATION; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; INFORMATION STORAGE AND RETRIEVAL; TELEMEDICINE;

EID: 84855608492     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-011-9611-z     Document Type: Conference Paper

References (34)

1. Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. (2001). Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart, 86, 516-521. (Pubitemid 32999861)
2. Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. (2002). A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. American Journal of Medicine, 113, 359-364. (Pubitemid 35223606)
3. Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., et al. (2000). Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation, 114, 119-125.
4. Camm, A. J., Kirchhof, P., Lip, G. Y., Schotten, U., Savelieva, I., Ernst, S., et al. (2010). Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) ; Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, Aug. 29 [Epub ahead of print].
5. Benjamin, E. J., Wolf, P. A., D'Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98, 946-952. (Pubitemid 28446646)
6. Flaker, G. C., Belew, K., Beckman, K., Vidaillet, H., Kron, J., Safford, R., et al. (2005). Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American Heart Journal, 149, 657-663.
7. Ziegler, P. D., Koehler, J. L., & Mehra, R. (2006). Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm, 3, 1445-1452. (Pubitemid 44849366)
8. Botto, G. L., Padeletti, L., Santini, M., Capucci, A., Gulizia, M., Zolezzi, F., et al. (2009). Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. Journal of Cardiovascular Electrophysiology, 20, 241-248.
9. Olson, J. A., Fouts, A. M., Padanilam, B. J., & Prystowsky, E. N. (2007). Utility of mobile cardiac outpatient telemetry for the diagnosis of palpitations, presyncope, syncope, and the assessment of therapy efficacy. Journal of Cardiovascular Electrophysiology, 18, 473-477. (Pubitemid 46650336)
10. Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC) ; European Heart Rhythm Association (EHRA) ; Heart Failure Association (HFA) ; Heart Rhythm Society (HRS), Moya, A., Sutton, R., Ammirati, F., Blanc, J. J., Brignole, M., et al. (2009). Guidelines for the diagnosis and management of syncope (version 2009). European Heart Journal, 30(21), 2631-1671.
11. Anand, I. S., Greenberg, B. H., Fogoros, R. N., Libbus, I., Katra, R. P., & Investigators, M. (2011). Design of the Multi-Sensor Monitoring in Congestive Heart Failure (MUSIC) study: prospective trial to assess the utility of continuous wireless physiologic monitoring in heart failure. Journal of Cardiac Failure, 17(1), 11-16.
12. Psaty, B. M., Manolio, T. A., Kuller, L. H., et al. (1997). Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 96, 2455-2461. (Pubitemid 27425856)
13. Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994). Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). American Journal of Cardiology, 74, 236-241. (Pubitemid 24239044)
14. Kinlay, S., Leitch, J. W., Neil, A., Chapman, B. L., Hardy, D. B., & Fletcher, P. J. (1996). Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. Annals of Internal Medicine, 124, 16-20. (Pubitemid 26019619)
15. Roche, F., Gaspoz, J. M., Da Costa, A., et al. (2005). Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter. Pacing and Clinical Electrophysiology, 25, 1587-1593. (Pubitemid 35398919)
16. Jabaudon, D., Sztajzel, J., Sievert, K., Landis, T., & Sztajzel, R. (2004). Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke, 35, 1647-1651. (Pubitemid 38823640)
17. Fetsch, T., Bauer, P., Engberding, R., et al. (2004). Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. European Heart Journal, 25, 1385-1394. (Pubitemid 39078247)
18. Israel, C. W., Gronefeld, G., Ehrlich, J. R., Li, Y. G., & Hohnloser, S. H. (2004). Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. Journal of the Am College of Cardiologists, 43, 47-52. (Pubitemid 38045914)
19. Quirino, G., Giammaria, M., Corbucci, G., Pistelli, P., Turri, E., Mazza, A., et al. (2009). Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: relationship to symptoms and other variables. Pacing and Clinical Electrophysiology, 32, 91-98.
20. Saksena, S., Hettrick, D. A., Koehler, J. L., Grammatico, A., & Padeletti, L. (2007). Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. American Heart Journal, 154(5), 884-892. (Pubitemid 350001285)
21. Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., Sweeney, M. O., Yee, R., Marinchak, R., et al. (2003). Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke. Circulation, 107, 1614-1619.
22. Capucci, A., Santini, M., Padeletti, L., Gulizia, M., Botto, G., Boriani, G., et al. (2005). Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. Journal of the Am College of Cardiologists, 46, 1913-1920. (Pubitemid 41579816)
23. Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Ezekowitz, M. D., Hilker, C., et al. (2009). The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk. The TRENDS Study. Circulation: Arrhythmias and Electrophysiology, 2, 474-480.
24. Ip, J., Waldo, A. L., Lip, G. Y. H., Rothwell, P. M., Martin, D. T., Bersohn, M. M., et al. (2009). Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort: the IMPACT study. American Heart Journal, 158, 364-370.e1.
25. Hindricks, G., Pokushalov, E., Urban, L., Taborsky, M., Kuck, K. H., Lebedev, D., et al. on behalf of the XPECT Trial investigators (2010). Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation. Results of the XPECT Trial. Circulation: Arrhythmias and Electrophysiology, 3, 141-147.
26. Hanke, T, Charitos, E. I., Stierle, U., Karluss, A., Kraatz, E., Graf, B., et al. (2009). Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy: up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation, 120 (11 Suppl), S177-S184.
27. Pokushalov, E., Romanov, A., Artyomenko, S., Turov, A., Shugayev, P., Shirokova, N., et al. (2010). Ganglionated plexi ablation for longstanding persistent atrial fibrillation. Europace, 12, 342-346.
28. Pokushalov, E., Romanov, A., Artyomenko, S., Turov, A., Shirokova, N., & Katritsis, D. G (2010). Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation. Pacing and Clinical Electrophysiology, 33(10), 1231-1238.
29. Corbucci, G, Urban, L., Hatala, R., Jongen, T, De Melis, M. (2010). Reliability of atrial fibrillation burden through subcutaneous devices. Europace, 12 (suppl 1), abstract 1811.
30. Amellone, C, Giuggia, M., Trapani, G, Giordano, B., Ceresa, M., Fazzari, M., et al. (2010). Rhythm surveillance after atrial fibrillation ablation: comparison between conventional follow up and a novel implantable continuous cardiac rhythm monitoring device. Heart Rhythm, 7(5) May Supplement, AB04-AB05.
31. Chun, K. R., Köster, I., Metzner, A., Fürnkranz, A., Schmidt, B., Ouyang, F., et al. (2010). Cryoballoon applications after acute pulmonary vein isolation-the Alster Extra Study. Heart Rhythm, 7(5) May Supplement: P06-P49.
32. Sinha, A. M., Diener, H. C, Morillo, C. A., Sanna, T, Bernstein, R. A., Di Lazzaro, V., et al. (2010). Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF) : design and rationale. American Heart Journal, 160, 36-41.
33. Arya, A., Silberbauer, J., Teichman, S. L., Milner, P., Sulke, N., & Camm, A. J. (2009). A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology. Europace, 11(4), 458-464.
34. Kirchhof, P., Bax, J., Blomstrom-Lundquist, C, Calkins, H., Camm, A. J., Cappato, R., et al. (2009). Early and comprehensive management of atrial fibrillation: proceedings from the IIAFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation. Europace, 11, 860-885.